| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |